CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Medivir AB Company Snapshot
Medivir AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medivir AB with three other companies in this sector in Sweden: Bioinvent International AB (2017 sales of 45.01 million Swedish Kronor [US$4.95 million] of which 100% was Drug Development), Sprint Bioscience AB (23.97 million Swedish Kronor [US$2.64 million] ), and Intervacc AB (48.00 million Swedish Kronor [US$5.28 million] ).

Sales Analysis. Medivir AB reported sales of SEK 36.64 million (US$4.03 million) for the year ending December of 2017. This represents a sharp decrease of 60.6% versus 2016, when the company's sales were SEK 93.04 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Medivir AB
  Stock Performance Chart for Medivir AB
 
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): 30.35
(Figures in Swedish Kronor)
1 Week -10.9%   13 Weeks -16.8%  
4 Weeks -14.9%   52 Weeks -49.8%  
 
Medivir AB Key Data:
  Ticker: MVIR-B Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 36,639,000
(Year Ending Jan 2018).
Employees: 88
  Currency: Swedish Kronor Market Cap: 737,140,800
  Fiscal Yr Ends: December Shares Outstanding: 24,288,000
  Share Type: B Fri Aktie Closely Held Shares: 5,209,642
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.